Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1989 May;67(1):132–134.

The role of T cells in mouse cytomegalovirus myocarditis.

C M Lawson 1, H O'Donoghue 1, W D Reed 1
PMCID: PMC1385302  PMID: 2544512

Abstract

BALB/c mice infected with murine cytomegalovirus (MCMV) developed myocarditis. Athymic nu/nu mice infected with the virus did not develop myocarditis, in contrast to heterozygous T-cell competent nu/+mice. MCMV-infected BALB/c mice given cyclosporin A(CsA) a drug which inhibits the activation of T cells, showed a delay in the development of myocarditis relative to CsA-untreated mice infected with MCMV. However, BALB/c mice infected with MCMV, regardless of CsA treatment, developed both anti-MCMV antibodies and autoantibodies. Nu/nu mice infected with MCMV did not produce the anti-MCMV antibody response or the multiple autoantibody response which was observed in nu/+ MCMV-infected mice. Both nu/nu and CsA-treated animals displayed greater organ distribution of viral antigen than control MCMV-infected animals. These results suggest that the presence of a thymus is required for both the development of myocarditis and the multiple autoantibody response, which includes autoantibodies to cardiac muscle, and that CsA immunosuppression does not abrogate either myocarditis or the antibody response in mice following MCMV infection.

Full text

PDF
132

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartholomaeus W. N., O'Donoghue H., Foti D., Lawson C. M., Shellam G. R., Reed W. D. Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies. Immunology. 1988 Jul;64(3):397–405. [PMC free article] [PubMed] [Google Scholar]
  2. Estrin M., Smith C., Huber S. Coxsackievirus B-3 myocarditis. T-cell autoimmunity to heart antigens is resistant to cyclosporin-A treatment. Am J Pathol. 1986 Nov;125(2):244–251. [PMC free article] [PubMed] [Google Scholar]
  3. Grundy J. E., Melief C. J. Effect of Nu/Nu gene on genetically determined resistance to murine cytomegalovirus. J Gen Virol. 1982 Jul;61(Pt 50):133–136. doi: 10.1099/0022-1317-61-1-133. [DOI] [PubMed] [Google Scholar]
  4. Hutchinson I. F., Shadur C. A., Duarte J. S., Strom T. B., Tilney N. L. Cyclosporin A spares selectively lymphocytes with donor-specific suppressor characteristics. Transplantation. 1981 Sep;32(3):210–216. doi: 10.1097/00007890-198109000-00006. [DOI] [PubMed] [Google Scholar]
  5. Kishimoto C., Kuribayashi K., Masuda T., Tomioka N., Kawai C. Animal model of silent myocarditis in athymic mice. Cardiovasc Res. 1986 Oct;20(10):768–773. doi: 10.1093/cvr/20.10.768. [DOI] [PubMed] [Google Scholar]
  6. Lawson C. M., Grundy J. E., Shellam G. R. Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice. J Gen Virol. 1988 Aug;69(Pt 8):1987–1998. doi: 10.1099/0022-1317-69-8-1987. [DOI] [PubMed] [Google Scholar]
  7. Lawson C. M., Grundy J. E., Shellam G. R. Delayed-type hypersensitivity responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice. J Gen Virol. 1987 Sep;68(Pt 9):2379–2388. doi: 10.1099/0022-1317-68-9-2379. [DOI] [PubMed] [Google Scholar]
  8. Monrad E. S., Matsumori A., Murphy J. C., Fox J. G., Crumpacker C. S., Abelmann W. H. Therapy with cyclosporine in experimental murine myocarditis with encephalomyocarditis virus. Circulation. 1986 May;73(5):1058–1064. doi: 10.1161/01.cir.73.5.1058. [DOI] [PubMed] [Google Scholar]
  9. Shanley J. D., Pesanti E. L. Murine cytomegalovirus adrenalitis in athymic nude mice. Arch Virol. 1986;88(1-2):27–35. doi: 10.1007/BF01310887. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES